Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 11,515

Document Document Title
WO/2020/189201A1
This method for producing bisphenol includes: a step for mixing an organic phase 1 that contains bisphenol, the organic phase 1 being in a mixed solution 1 of an aqueous phase 1 and the organic phase 1, with a chelating agent to obtain a...  
WO/2020/184182A1
Provided is a bisphenol composition that has a bisphenol content of at least 95 mass% and contains at least 200 ppm by mass of a compound represented by general formula (II). Also provided is polycarbonate resin production method using t...  
WO/2020/184183A1
Provided is a bisphenol composition that has a bisphenol content of at least 95 mass%, contains at least 150 ppm by mass of a bisphenol represented by general formula (II), and has a methanol solution color (Hazen Color Index) of not gre...  
WO/2020/183370A1
Systems and methods for indicating an effect onset period of a cannabis product including an effect onset device having a timing mechanism to track the effect onset period. The effect onset device including a processor having an activati...  
WO/2020/154811A9
An object of the present invention is to provide a compound for modulating expression of Major Histocompatibility Complex Class I (MHC-1) and/or TAP-1, in eukaryotic cells. In certain aspects, the compound is a curcuphenol, a terpene or ...  
WO/2020/185661A1
The present invention provides a method of treating or mitigating seizures comprising compounds as described herein.  
WO/2020/178053A1
Phenol derivatives of general formula (I) and (II), wherein meanings of the substituents are indicated in the description, their pharmaceutically acceptable salts, together with the processes for their preparation, their use as antimicro...  
WO/2020/175495A1
Provided is a method for producing a salt by reacting M+X- with YH so as to generate XH and M+Y-, and then removing the generated XH so as to obtain M+Y-. M+X- is a salt of a cation represented by M+ and an anion represented by X-. M+Y- ...  
WO/2020/168421A1
The invention provides cyclodextrin inclusion complexes of cannabis extracts, cannabinoids and cannabis terpenes, and methods of making such complexes. The cyclodextrin inclusion complexes include a host and guest compounds. The host may...  
WO/2020/169135A1
The invention relates to a method for preparing cannabidiol and to an intermediate for preparing cannabidiol, wherein two intermediate are obtained, that is, a silylated olivetol and a silylated olivetol (2) and bromated olivetol (4) whi...  
WO/2020/165902A1
The present invention provides methods of extraction of at least one cannabinoid from an initial cannabis biomass in "one-pot" step using toluene to form a toluene extract and using the toluene extract for producing high concentrations o...  
WO/2020/165715A1
Methods and systems for generating a cannabis-based therapy including an inhalable cannabis derived compound are disclosed. The methods and systems include a patient portal and a server having a matching system stored there, on the match...  
WO/2020/168155A1
A cocrystal of cannabidiol is disclosed, specifically a 1:1 cannabidiokL-pipecolic acid cocrystal The beneficial and therapeutic uses of the cocrystal and of compositions containing the cocrystal are also disclosed. The disclosure sets o...  
WO/2020/162408A1
The present invention has the effect of making it possible to produce 1,1,1-trifluoro-2,2-bisarylethane efficiently by a simple procedure by condensing a mixture of fluoral and hydrogen fluoride with an aryl compound under anhydrous cond...  
WO/2020/162876A1
Processes of producing cresols from a phenols containing feed are described. The processes involve a combination of dealkylation and transalkylation processes. The dealkylation process converts the heavy alkylphenols in an alkylphenols s...  
WO/2020/160677A1
Provided herein are formulations for treating affective mood disorders. The formulations comprise one or more than one CB receptor agonist and one or more than one serine hydrolase enzyme inhibitor.  
WO/2020/160652A1
Described is a method of selectively isolating non-rigid structure meroterpenes (for example, cannabidiolic acid) from a complex matrix that may also contain rigid structure meroterpenes (for example, THCa), comprising selectively precip...  
WO/2020/162877A1
Processes for making phenol and xylenes from a phenols-containing feed are described. The processes involve transalkylation of alkylphenols to form phenol and alkylbenzenes. The phenol is separated from the alkylbenzenes, and the alkylbe...  
WO/2020/158931A1
The purpose of the present invention is to provide: a novel compound which is useful as a film forming material for lithography or as a material for forming an optical component; a resin which contains a constituent unit that is derived ...  
WO/2020/154811A1
An object of the present invention is to provide a compound for modulating expression of Major Histocompatibility Complex Class I (MHC-1) and/or TAP-1, in eukaryotic cells. In certain aspects, the compound is a curcuphenol, a terpene or ...  
WO/2020/155595A1
Disclosed are an aerobic oxidation system and a photocatalytic aerobic oxidation method therefor. The aerobic oxidation system comprises: 1) at least one of the following substances 1a) -1d): 1a) sulfinic acid or a derivative thereof; 1b...  
WO/2020/159103A1
The present invention relates to a hydroquinone-resorcinol complex inclusion compound and a method for capturing or storing a low-molecular gas using same, and specifically, to a hydroquinone-resorcinol complex inclusion compound that ca...  
WO/2020/076485A3
The present invention relates to nucleic acid molecules from regions of Enterococcus spp. genomes which are associated with the production of dopamine. The invention also relates to proteins encoded by such nucleic acid molecules as well...  
WO/2019/195761A3
Methods of treating presbyopia or cataract in a subject in need thereof are provided, The methods require administering to the subject an effective amount of a composition comprising a compound that inhibits the formation of high molecul...  
WO/2020/102901A8
Provided herein are synthetic compounds useful for inhibiting bacterial growth and uses thereof. Also provided are pharmaceutical compositions. The compounds and pharmaceutical compositions are useful for inhibiting growth of a bacterium...  
WO/2020/136678A1
A PROCESS FOR PREPARATION OF TERTIARY BUTYL HYDROQUINONE The present invention relates to a process for preparation of tertiary butyl hydroquinone. More particularly, it relates to a process for preparation 5 of TBHQ by eradicating the c...  
WO/2020/128767A1
The invention relates to compositions comprising water-soluble complexes of a-cyclodextrin (alpha-cyclodextrin) and cannabinoids and/or complexes of a-cyclodextrin and cannabis-derived terpenes, methods of making these a-cyclodextrin com...  
WO/2020/130313A1
The present invention relates to a method for decomposing a phenolic by-product, and more particularly, to method for decomposing a phenolic by-product produced during a phenol production process, the method comprising the steps of: (S10...  
WO/2020/124220A1
Provided are pharmaceutical compositions comprising cannabis such that when combusted produces cannabidiolic acid (CBDA) for inhalation. Also provided are pharmaceutical composition for inhalation by a subject comprising tetrahydrocannab...  
WO/2020/047370A3
Disclosed are novel catechol dditives and the like, methods of preparing, as well as compositions and methods using such compositions in various applications. Also provided is a method of preparing an aqueous coating composition such as ...  
WO/2020/124211A1
Press cake material is extracted with 80-100C water for up to 5 hours. The liquid is separated from the solid material, and the liquid is fermented/decarboxylated with suitable micro-organisms and/or suitable enzymes. The treated liquid ...  
WO/2020/130314A1
The present invention relates to a method and an apparatus for decomposing a phenolic byproduct, the decomposing method comprising the steps of: (S10) supplying the phenolic byproduct to a reactive multistage distillation column; (S20) s...  
WO/2020/124268A1
Methods for making oleosome-based cannabinoid formulations are disclosed herein. The methods include preparing and/or providing an oleosome suspension from a selected plant species, then combining the oleosome suspension with one or more...  
WO/2020/119595A1
Provided are a phenol salt and application thereof as a catalyst in a hexavalent sulfur-fluoride exchange reaction, said phenol salt comprising cations and anions. The phenol salt is easy to synthesize and can be used as a catalyst for a...  
WO/2020/123407A1
Some embodiments pertain to nanoparticle-based compositions and their use in methods for the delivery of CBD to subjects. In some embodiments, the compositions are stable for prolonged periods of time and provide enhanced bioavailability.  
WO/2020/123365A1
Various aspects of this patent application relate to methods to separate a cannabinoid molecule from other molecules of a decarboxylated cannabinoid extract.  
WO/2020/118415A1
Cannabis-based self-emulsifying products such as self-emulsifying capsules are described herein together with methods for preparing such self-emulsifying products. In at least some embodiments, a self-emulsifying drug delivery system is ...  
WO/2020/114925A1
The invention relates to a method for producing a specific hydroxy compound by decarboxylating a specific carboxylic acid compound or a salt of said carboxylic acid compound in the presence of a Bronsted base. The invention also relates ...  
WO/2020/114928A1
The invention relates to a process for preparing a specific hydroxy compound by means of decarboxylation of a specific carboxylic acid compound or a salt of said carboxylic acid compound, to a method for preparing a diaryl carbonate, a b...  
WO/2020/116555A1
The present invention addresses the problem of providing: a liquid crystal composition which contains a polymerizable compound and which is used for producing a PSA type or PSVA type liquid crystal display element, wherein the speed of p...  
WO/2020/114927A1
The invention relates to a method for producing a specific hydroxyl compound by decarboxylating a specific carboxylic acid compound or a salt of said carboxylic acid compound in the absence of a catalyst and to a method for producing a b...  
WO/2020/115078A1
The present invention relates to new lightly colored prills of hydroquinone. More particularly, the invention provides a new method for preparing said lightly colored prills of hydroquinone. The invention also relates to said prills of h...  
WO/2020/115936A1
The present invention addresses the problem of providing: a liquid crystal composition which contains a polymerizable compound for producing a PSA type or PSVA type liquid crystal display element that has a sufficient pretilt angle and e...  
WO/2020/107114A1
Water-soluble formulations including cannabinoids or a cannabis-derived compound for use in beverages and foods, methods of preparing the formulations, and methods of preparing beverages and foods including the formulations are disclosed...  
WO/2020/108989A1
The present inventions relates to the preparation of 3,3,5-trimethylcyclohexylidene bisphenol. Especially, the present invention relates to the preparation of 3,3,5- trimethylcyclohexylidene bisphenol from 3,3,5-trimethylcyclohexanone an...  
WO/2020/107119A1
Cannabis and cannabis-derived compositions, methods of making and methods of using the compositions in oral dosage forms, such as in beverage forms, are disclosed herein. The compositions comprise a cannabinoid or a cannabis-derived comp...  
WO/2020/109413A1
The instant invention concerns polymers obtained by radical copolymerization of a mixture of (1) acrylic acid; (2) methacrylic acid; and (3) at least one allylcatechol selected from 4-allylbenzene-1,2-diol, 3-allyl benzene-1,2-diol and m...  
WO/2020/102898A1
The present disclosure relates to a process for producing a cannabis concentrate from a cannabis plant material via extraction using supercritical carbon dioxide (CO2) at temperatures in excess of 65°C, thus permitting the selective ext...  
WO/2020/102901A1
Provided herein are synthetic compounds useful for inhibiting bacterial growth and uses thereof. Also provided are pharmaceutical compositions. The compounds and pharmaceutical compositions are useful for inhibiting growth of a bacterium...  
WO/2020/099283A1
A process for the synthesis of Cannabidiol of formula (1): (1) is herein disclosed. The process comprises contacting a solution [solution (S1)] of (+)-p-mentha-diene-3-ol of formula (4) (4) or an ester thereof and olivetol of formula (3)...  

Matches 1 - 50 out of 11,515